Features | Partner Sites | Information | LinkXpress
Sign In
PURITAN MEDICAL
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC

Cell Imaging System Emphasizes Speed and Sensitivity

By BiotechDaily International staff writers
Posted on 26 Dec 2012
The most recent version of a high-speed cell imaging system designed for both screening and research has now been released to the biotech and life science markets.

The GE Healthcare (Chalfont St. Giles, United Kingdom) IN Cell Analyzer 2200 is a high-speed, flexible, modular imaging system suitable for both investigative microscopy and automated high-content screening of organelles, cells, tissues, and whole organisms.

For screening applications a combination of proprietary optics, a choice of large or standard chip camera, and fast hardware and software autofocus capabilities deliver accurate, high-speed imaging. A bright light source reduces exposure times to further maximize speed without compromising image quality and cell health while the rapid image restoration options allow confocal-like images to be obtained.

A variety of innovative imaging features and a wide range of objectives (2 to 100 times) gives exceptional flexibility for real-time research use. The manual microscope mode allows manipulation of images at full size and resolution, in and out zoom capability, and manual settings adjustments (e.g., filters, objectives, and z-height).

The instrument can image a two-colored 96-well plate assay in about 150 seconds and a one-color 1,536 plate in less than 20 minutes. This speed is possible due to a bright, seven-wavelength solid-state light source and scientific-grade CMOS camera coupled with an optimized stage and efficient, easy-to-use control software. Furthermore, the system is designed to maximize the quantitative accuracy of captured images for any sample type, including image restoration for dim samples.

Related Links:

GE Healthcare



Channels

Genomics/Proteomics

view channel
Image: Researchers have generated disease-free stem cells from patients with mitochondrial disease that can be converted into any cell type including neuronal progenitors (left) or heart cells (right). These could potentially be used for future transplantation into patients (Photo courtesy of Salk Institute of Biological Studies).

Methods Developed to Generate Normal Stem Cells from Patients with Mitochondrial Defects

A recent paper described two methods for converting cells from patients with mitochondrial defects into normal pluripotent stem cells that could be induced to differentiate into several different types of tissues.... Read more

Drug Discovery

view channel
Image: A new micelle delivery system for the protective polyphenols resveratrol and quercetin (mRQ) may have value in cancer chemotherapy (Photo courtesy of Oregon State University).

Micelles Containing Resveratrol and Quercetin Reverse Doxorubicin Cardiotoxicity

Cancer researchers blocked the toxic effects of the cancer drug doxorubicin (DOX) by administering it together with the plant antioxidants resveratrol and quercetin. Although in use for more than 40... Read more

Business

view channel

Teva Buys Allergan Generic Business Unit

Teva Pharmaceutical Industries (Petah Tikva, Israel) has bought the Allergan (Irvine, CA, USA) generic drugs business for USD 40.5 billion in cash and stock, solidifying its position as the world's largest generic drug maker. Under the terms of the agreement, Teva will pay USD 33.75 billion in cash and USD 6.... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.